E Fund Management Co., Ltd. Zai Lab LTD Transaction History

E Fund Management Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$30.21 - $48.1 $6.72 Million - $10.7 Million	-222,452 Reduced 72.93%	82,587 $2.75 Million
Q4 2022 Feb 14, 2023	BUY	$22.28 - $38.71 $5.47 Million - $9.5 Million	245,449 Added 411.9%	305,039 $2.15 Million
Q2 2022 Aug 15, 2022	BUY	$23.14 - $49.68 $1.38 Million - $2.96 Million	59,590 New	59,590 $2.07 Million
Q1 2022 May 12, 2022	SELL	$27.77 - $64.4 $526,602 - $1.22 Million	-18,963 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$54.9 - $105.21 $1.04 Million - $2 Million	18,963 New	18,963 $1.19 Million

116

40.8M

63.1K

420K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.02B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.